Evidence map›Paper›PMID 32720191›Full record

ArticleArchives of toxicology2020

Correction to: Multiparametric assessment of mitochondrial respiratory inhibition in HepG2 and RPTEC/TERT1 cells using a panel of mitochondrial targeting agrochemicals.

Wanda van der Stel, Giada Carta, Julie Eakins, Salihanur Darici, Johannes Delp, Anna Forsby, Susanne Hougaard Bennekou, Iain Gardner, Marcel Leist, Erik H J Danen and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Wanda van der StelDivision of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Giada CartaDivision of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, AIMMS, Vrije Universiteit Amsterdam, De Boelelaan, 1108, 1081 HZ, Amsterdam, The Netherlands.
Julie EakinsCyprotex Discovery Ltd, Alderley Park, Macclesfield, Cheshire, UK.
Salihanur DariciDivision of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Johannes DelpUniversity of Konstanz, Constance, Germany.
Anna ForsbyDepartment of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Susanne Hougaard BennekouNational Food Institute Technical University of Denmark (DTU), Lyngby, Denmark.
Iain GardnerCertara UK Limited, Sheffield, UK.
Marcel LeistUniversity of Konstanz, Constance, Germany.
Erik H J DanenDivision of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Paul WalkerCyprotex Discovery Ltd, Alderley Park, Macclesfield, Cheshire, UK.
Bob van de WaterDivision of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. water_b@lacdr.leidenuniv.nl.
Paul JenningsDivision of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, AIMMS, Vrije Universiteit Amsterdam, De Boelelaan, 1108, 1081 HZ, Amsterdam, The Netherlands. p.jennings@vu.nl.ORCID http://orcid.org/0000-0002-6860-2898

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of the article.

Identifiers

PMID32720191
PMCPMC7645484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.